PubRank

Philippe Généreux

Author PubWeight™ 34.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013 4.16
2 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012 2.78
3 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 2012 1.99
4 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 2012 1.74
5 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 2012 1.72
6 Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study. EuroIntervention 2014 1.57
7 SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter Cardiovasc Interv 2014 1.45
8 Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheter Cardiovasc Interv 2013 1.45
9 Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv 2014 1.40
10 Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. Coron Artery Dis 2016 1.38
11 von Willebrand Disease After TAVR: The Missing Link? JACC Cardiovasc Interv 2015 1.08
12 Exploring the Role of Transcatheter Aortic Valve Replacement as the Preferred Treatment for Lower-Risk Patients. J Am Coll Cardiol 2015 1.07
13 On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab 2005 1.04
14 Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol 2013 0.98
15 Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol 2013 0.95
16 Asymptomatic Severe Aortic Stenosis: Oxymoron? J Am Coll Cardiol 2016 0.87
17 Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial. Circ Cardiovasc Interv 2011 0.86
18 Zotarolimus- and paclitaxel-eluting stents in an all-comer population in China: the RESOLUTE China randomized controlled trial. JACC Cardiovasc Interv 2013 0.85
19 Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol 2013 0.83
20 Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention 2013 0.82
21 Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial). Am J Cardiol 2012 0.80
22 A randomized trial comparing dual axis rotational versus conventional coronary angiography in a population with a high prevalence of coronary artery disease. J Interv Cardiol 2014 0.80
23 Patient radiation exposure during transcatheter aortic valve replacement procedures. EuroIntervention 2012 0.78
24 Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). Am J Cardiol 2013 0.78
25 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention 2012 0.78
26 Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score. JACC Cardiovasc Interv 2013 0.78
27 Valve-in-valve implantation with a 23-mm balloon-expandable transcatheter heart valve for the treatment of a 19-mm stentless bioprosthesis severe aortic regurgitation using a strategy of "extreme" underfilling. Catheter Cardiovasc Interv 2014 0.77
28 In vitro validation and comparison of different software packages or algorithms for coronary bifurcation analysis using calibrated phantoms: implications for clinical practice and research of bifurcation stenting. Catheter Cardiovasc Interv 2014 0.77
29 Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance. Curr Cardiol Rep 2014 0.76
30 Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention 2014 0.76
31 Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 2015 0.75
32 Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. J Invasive Cardiol 2015 0.75
33 Early Hemodynamic Results in Patients With Small Aortic Annulus After Aortic Valve Replacement. Innovations (Phila) 2017 0.75
34 Revascularization Strategies for Calcified Lesions in Patients Presenting With Acute Coronary Syndromes (From the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial). J Invasive Cardiol 2016 0.75
35 The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial. J Invasive Cardiol 2015 0.75
36 Reply: Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve. JACC Cardiovasc Interv 2017 0.75
37 Percutaneous left atrial appendage occlusion: putting the most lethal human attachment behind bars. Arq Bras Cardiol 2012 0.75
38 Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement. Circ Cardiovasc Interv 2013 0.75
39 Quantitative Angiography Methods for Bifurcation Lesions: A Consensus Statement Update from the European Bifurcation Group. EuroIntervention 2017 0.75
40 Guiding Light: Insights Into Atherectomy by Optical Coherence Tomography. JACC Cardiovasc Interv 2016 0.75
41 Novel Crossing System for the Recanalization of Complex Chronic Total Occlusions: Ex vivo Proof of Concept of the SoundBite Crossing System. J Invasive Cardiol 2017 0.75
42 The Tryton Side Branch Stent. EuroIntervention 2015 0.75
43 Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Coron Artery Dis 2016 0.75